It's not just 'chronic fatigue': ME/CFS is much more than being tired
Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is as complex as its name is difficult to pronounce. It's sometimes referred to as simply "chronic fatigue", but this is just one of its symptoms.
In fact, ME/CFS is a complex neurological disease, recognised by the World Health Organization, that affects nearly every system in the body.
The name refers to muscle pain (myalgia), inflammation of the brain (encephalomyelitis), and a profound, disabling fatigue that rest can't relieve.
However, the illness's complexity – and its disproportionate impact on women – means ME/CFS has often been incorrectly labelled as a psychological disorder.
What is ME/CFS?
ADVERTISEMENT
ME/CFS affects people of all ages but is most commonly diagnosed in middle age. It is two to three times more common in women than men.
While the exact cause is unknown, ME/CFS is commonly triggered by an infection.
The condition has two core symptoms: a disabling, long-lasting fatigue that rest doesn't relieve, and a worsening of symptoms after physical or mental exertion.
This is known as post-exertional malaise. It means even slight exertion can make symptoms much worse, and take much longer than expected to recover.
This varies between people, but could mean simply having a shower or attending a social event triggers worse symptoms, either immediately or days later.
These symptoms include pain, sleep issues, cognitive difficulties (such as thinking, memory and decision-making), flu-like symptoms, dizziness, gastrointestinal problems, heart rate fluctuations and many more.
For some people, symptoms can be managed in a way that allows them to work. For others, the disease is so severe it can leave them housebound or bedridden.
ADVERTISEMENT
Symptoms can fluctuate, changing over time and in intensity, making ME/CFS a particularly unpredictable and misunderstood condition.
Not just 'in your head'
A person at home (file image). (Source: istock.com)
A growing body of scientific evidence, however, clearly shows ME/CFS is a biological, not mental, illness.
Neuroimaging studies have revealed differences in the brain activity and structure of people with ME/CFS, including poor blood flow and lower levels of neurotransmitters (chemical messengers in the nervous system).
Other research indicates the condition affects how the body produces energy (the metabolism), fights infection (the immune system), delivers oxygen to muscles and tissues, and regulates blood pressure and heart rate (the vascular system).
Issues with criteria
ADVERTISEMENT
To diagnose ME/CFS, a clinician will also exclude other possible causes of fatigue, which can be a lengthy process. A patient needs to meet a set of clinical criteria.
But one of the major challenges in researching ME/CFS is that the diagnostic criteria clinicians use vary worldwide.
Some criteria focus solely on fatigue and include people with alternate reasons for fatigue, such as a psychiatric disorder.
Others are more narrow and may only capture ME/CFS patients with more severe symptoms.
As a result, it can be very difficult to compare across different studies, as the reasons they include or exclude participants vary so much.
Changes to the guidelines
In Australia, doctors often receive little formal education about ME/CFS.
ADVERTISEMENT
Most commonly, they follow the Royal Australian College of General Practitioners' clinical guidelines to diagnose and manage ME/CFS. These are based on the Canadian Consensus Criteria which are considered more stringent than other ME/CFS diagnostic criteria.
They include post-exertional malaise and fatigue for more than six months as core symptoms.
However, these guidelines are outdated and rely heavily on controversial studies that assumed the primary cause of ME/CFS was 'deconditioning' – a loss of physical strength due to a fear or avoidance of exercise.
These guidelines recommend ME/CFS should be treated with cognitive behavioural therapy – a common psychotherapy which focuses on changing unhealthy thoughts and behaviours – and graded exercise therapy, which gradually introduces more demanding physical activity.
While cognitive behaviour therapy can be effective for some people managing ME/CFS, it's important not to frame this condition primarily as a psychological issue.
Graded exercise therapy can encourage people to push beyond their 'energy envelope', which means they do more than their body can manage. This can trigger post-exertional malaise and a worsening of symptoms.
In June 2024, the Australian government announced A$1.1 million (NZ$1.2 million) towards developing new clinical guidelines for diagnosing and managing ME/CFS.
ADVERTISEMENT
Leading organisations have scrapped the recommendation of graded exercise therapy in the United States (in 2015) and the United Kingdom (in 2021). Hopefully Australia will follow suit.
What can people with ME/CFS do?
While we wait for updated clinical guidelines, 'pacing' – or working within your energy envelope – has shown some success in managing symptoms. This means monitoring and limiting how much energy you expend.
Some evidence also suggests people who rest in the early stages of their initial illness often experience better long-term outcomes with ME/CFS.
This is especially relevant after the Covid-19 pandemic and with the emergence of long Covid. Studies indicate more than half of those affected meet stringent clinical criteria for ME/CFS.
In times of acute illness we should resist the temptation to push through. Choosing to rest may be a crucial step in preventing a condition that is much more debilitating than the original infection.
Author: Sarah Annesley is a senior postdoctoral research fellow in cell and molecular biology at La Trobe University in Melbourne, Australia
This article is republished from The Conversation under a Creative Commons licence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
a day ago
- Otago Daily Times
NZ vaccination rate low among high income countries
Between 2010 and 2019, progress in increasing vaccinations stalled and even reversed in some countries, including in 21 of 36 high-income countries such as Canada, France, Germany, Italy, Japan, UK, and US. Australia had the sixth highest number of unvaccinated children in 2023 among high-income countries. New Zealand and Australia had the sixth and seventh lowest percentage of vaccine coverage, respectively in 2023 among high-income countries. By 2030, only the high-income super region is projected to reach the World Health Organization's 2030 immunisation targets, unless drastic changes are made in the next five years. Childhood vaccination rates have dropped in 21 out of 36 high-income countries, with New Zealand ranking among the lowest in terms of coverage, new research has found. According to the major new analysis from the Global Burden of Disease Study Vaccine Coverage Collaborators, published in The Lancet on Wednesday New Zealand had the sixth lowest rate of coverage in 2023, just behind Australia. Only Canada, San Marino, Ireland, Austria and Argentina had worse childhood vaccination coverage. Since the World Health Organisation established the Expanded Programme on Immunization (EPI) in 1974, more than 4 billion children had been vaccinated, preventing the deaths of an estimated 154 million children. Initially focusing on six childhood vaccine-preventable diseases (tuberculosis, diphtheria, pertussis, tetanus, polio, and measles), the programme later expanded to include protection against Haemophilus influenzae type B, Hepatitis B, rubella, pneumococcal disease, rotavirus, and human papillomavirus. However, the last two decades have also been marked by stagnating childhood vaccination rates and "wide variation" in coverage - a trend further exacerbated by the Covid-19 pandemic, the report noted. "Between 2010 and 2019, coverage gains slowed and, in some areas of the world, reversed. "For example, 21 of 36 high-income countries experienced declines in coverage for at least one of the original EPI-recommended vaccine-doses (excluding the tuberculosis vaccine, which is no longer included in routine immunisation schedules in some countries) - including a 12% decline in first dose measles vaccination in Argentina, and 8% and 6% declines in third dose diphtheria-tetanus-pertussis vaccination in Finland and Austria, respectively. "Additionally, the proportion of children receiving the measles vaccine declined in 100 of 204 countries, with the largest decrease observed in Latin America and the Caribbean, where coverage fell from around 90% in 2010 to 87% in 2019, resulting in almost one million fewer children being vaccinated against measles in 2019." Children left vulnerable Lead author Dr Jonathan Mosser from the Institute for Health Metrics and Evaluation at the University of Washington said this left millions of "under and un-vaccinated" children vulnerable to preventable disease and death. "Routine childhood vaccinations are among the most powerful and cost-effective public health interventions available, but persistent global inequalities, challenges from the COpandemic, and the growth of vaccine misinformation and hesitancy have all contributed to faltering immunisation progress," he said. "These trends increase the risk of outbreaks of vaccine-preventable diseases, including measles, polio, and diphtheria, underscoring the critical need for targeted improvements to ensure that all children can benefit from lifesaving immunisations." In 2023, more than half of the world's 15.7m unvaccinated children were living in just eight countries, with 53% in sub-Saharan Africa. Vaccine-preventable disease outbreaks persisted, including polio in Pakistan, Afghanistan and Papua New Guinea, where less than half the population is immunised. In 2024, there was a nearly tenfold increase in measles infections recorded in the European Union and the European Economic Area, while the ongoing measles outbreak in the United States reached over 1000 confirmed cases across 30 states by May 2025. The authors stressed that global immunisation goals for 2030 would not be met without targeted strategies and "efforts to tackle vaccine misinformation and hesitancy".
1News
4 days ago
- 1News
It's not just 'chronic fatigue': ME/CFS is much more than being tired
Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is as complex as its name is difficult to pronounce. It's sometimes referred to as simply "chronic fatigue", but this is just one of its symptoms. In fact, ME/CFS is a complex neurological disease, recognised by the World Health Organization, that affects nearly every system in the body. The name refers to muscle pain (myalgia), inflammation of the brain (encephalomyelitis), and a profound, disabling fatigue that rest can't relieve. However, the illness's complexity – and its disproportionate impact on women – means ME/CFS has often been incorrectly labelled as a psychological disorder. What is ME/CFS? ADVERTISEMENT ME/CFS affects people of all ages but is most commonly diagnosed in middle age. It is two to three times more common in women than men. While the exact cause is unknown, ME/CFS is commonly triggered by an infection. The condition has two core symptoms: a disabling, long-lasting fatigue that rest doesn't relieve, and a worsening of symptoms after physical or mental exertion. This is known as post-exertional malaise. It means even slight exertion can make symptoms much worse, and take much longer than expected to recover. This varies between people, but could mean simply having a shower or attending a social event triggers worse symptoms, either immediately or days later. These symptoms include pain, sleep issues, cognitive difficulties (such as thinking, memory and decision-making), flu-like symptoms, dizziness, gastrointestinal problems, heart rate fluctuations and many more. For some people, symptoms can be managed in a way that allows them to work. For others, the disease is so severe it can leave them housebound or bedridden. ADVERTISEMENT Symptoms can fluctuate, changing over time and in intensity, making ME/CFS a particularly unpredictable and misunderstood condition. Not just 'in your head' A person at home (file image). (Source: A growing body of scientific evidence, however, clearly shows ME/CFS is a biological, not mental, illness. Neuroimaging studies have revealed differences in the brain activity and structure of people with ME/CFS, including poor blood flow and lower levels of neurotransmitters (chemical messengers in the nervous system). Other research indicates the condition affects how the body produces energy (the metabolism), fights infection (the immune system), delivers oxygen to muscles and tissues, and regulates blood pressure and heart rate (the vascular system). Issues with criteria ADVERTISEMENT To diagnose ME/CFS, a clinician will also exclude other possible causes of fatigue, which can be a lengthy process. A patient needs to meet a set of clinical criteria. But one of the major challenges in researching ME/CFS is that the diagnostic criteria clinicians use vary worldwide. Some criteria focus solely on fatigue and include people with alternate reasons for fatigue, such as a psychiatric disorder. Others are more narrow and may only capture ME/CFS patients with more severe symptoms. As a result, it can be very difficult to compare across different studies, as the reasons they include or exclude participants vary so much. Changes to the guidelines In Australia, doctors often receive little formal education about ME/CFS. ADVERTISEMENT Most commonly, they follow the Royal Australian College of General Practitioners' clinical guidelines to diagnose and manage ME/CFS. These are based on the Canadian Consensus Criteria which are considered more stringent than other ME/CFS diagnostic criteria. They include post-exertional malaise and fatigue for more than six months as core symptoms. However, these guidelines are outdated and rely heavily on controversial studies that assumed the primary cause of ME/CFS was 'deconditioning' – a loss of physical strength due to a fear or avoidance of exercise. These guidelines recommend ME/CFS should be treated with cognitive behavioural therapy – a common psychotherapy which focuses on changing unhealthy thoughts and behaviours – and graded exercise therapy, which gradually introduces more demanding physical activity. While cognitive behaviour therapy can be effective for some people managing ME/CFS, it's important not to frame this condition primarily as a psychological issue. Graded exercise therapy can encourage people to push beyond their 'energy envelope', which means they do more than their body can manage. This can trigger post-exertional malaise and a worsening of symptoms. In June 2024, the Australian government announced A$1.1 million (NZ$1.2 million) towards developing new clinical guidelines for diagnosing and managing ME/CFS. ADVERTISEMENT Leading organisations have scrapped the recommendation of graded exercise therapy in the United States (in 2015) and the United Kingdom (in 2021). Hopefully Australia will follow suit. What can people with ME/CFS do? While we wait for updated clinical guidelines, 'pacing' – or working within your energy envelope – has shown some success in managing symptoms. This means monitoring and limiting how much energy you expend. Some evidence also suggests people who rest in the early stages of their initial illness often experience better long-term outcomes with ME/CFS. This is especially relevant after the Covid-19 pandemic and with the emergence of long Covid. Studies indicate more than half of those affected meet stringent clinical criteria for ME/CFS. In times of acute illness we should resist the temptation to push through. Choosing to rest may be a crucial step in preventing a condition that is much more debilitating than the original infection. Author: Sarah Annesley is a senior postdoctoral research fellow in cell and molecular biology at La Trobe University in Melbourne, Australia This article is republished from The Conversation under a Creative Commons licence.
Scoop
18-06-2025
- Scoop
Make Midwives Universally Accessible And Save Millions Of Lives, WHO Urges
18 June 2025 According to the World Health Organization (WHO), this sort of large-scale life-saving is possible, if midwifery care is universally accessible and consistent with international standards. ' Expanding and investing in midwifery models of care is one of the most effective strategies to improve maternal and newborn health globally,' said Dr. Anshu Banerjee, director for maternal, child and adolescent health and ageing at WHO. In a recently released report, WHO outlined how individual countries, with the support of the international community, can mobilise relevant stakeholders and institute policies which support midwives. Midwifery models of care Midwives worldwide work diligently to provide a continuum of care to women, including care surrounding sexual and reproductive health, pregnancy, childbirth and postnatal care. Emphasizing personalized and culturally conscious approaches, midwifery is especially helpful in reducing access barriers for women in rural or conflict-affected regions where hospitals may not be accessible. 'Skilled midwives help women trust in their bodies, their abilities and their care…ensuring women are consistently part of decision making and have access to the information they need,' said Ulrika Rehnstrom Loi, a midwifery expert at WHO. The WHO report emphasised that midwifery models of care are especially important as concerns of over-medicalisation in childbirth become more pronounced. 'In a world where childbirth is increasingly medicalised, [midwives] offer a person-centered evidence-based approach that respects the physiological process of birth, restores dignity and autonomy to maternity care,' said Anna Ugglas, Chief Executive of the International Confederation of Midwives. Implementing a global imperative Currently, the world faces a global shortage of around one million midwives. Concentrated and cross-sectoral action is needed to reverse this shortage. 'Midwifery models of care are not just smart solutions — they are a necessity,' Ms. Ugglas said. The WHO report outlined that increasing the number of midwives worldwide requires policy action across many sectors, including health and education, in addition to advocacy campaigns. In Morocco, the Association of Midwives conducted an awareness campaign which distributed flyers and cultivated partnerships with women and civil society organizations. This campaign ultimately led to legislation in 2016 which defined what midwifery was, the first of its kind in Morocco. Like the Moroccan example indicates, the report said that policymaking, advocacy and implementation must all happen simultaneously and that each country must adopt an approach which is specific to their context. '[Midwifery] approaches improve outcomes, maximize resources and can be adapted to all countries,' said Dr. Banerjee. Case study in rural midwifery A campaign in the West Bank led by the Palestinian Red Crescent Society, the Palestine Committee of Norway and the Palestinian Ministry of Health worked to address the challenges that women in rural areas face when accessing care. Through coordinating with hospitals and community members, the campaign expanded midwifery services to six regional hospitals and 37 villages between 2013 and 2016. This led to a 20 per cent decrease in unplanned caesarean sections and a 21 per cent decline in preterm birth rates. And these were just the short-term effects, but Mr. Banerjee said that expanded midwifery access can have longer-term effects too. '[Midwifery models of care] also enhance women's and families' experiences of care – building trusted partnerships for health at this critical stage of life.'
